Search

everythinglearnresearchcommunity

for

Search:↓

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

COVID-19 may harm male fertility and damage the reproductive system.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

People often underestimate hair loss severity, with fewer seeking treatment, and it's more distressing for women.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Higher blood sugar levels may lead to more severe hair loss in women.

AGA patients have a lower quality of life than AA patients.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

Regular aerobic exercise for over 60 minutes can delay and improve androgenic alopecia symptoms.

Women find hair loss more distressing than men and often underestimate it, needing more public awareness and professional support.

Phototrichogram helps assess hair loss severity.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

The Modified Wash Test is reliable for diagnosing hair loss conditions and determining treatment priority.

58% of men aged 30-50 have hair loss, with severity increasing with age.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Higher substance P levels may cause discomfort in hair loss patients.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Targeting IL-17 could help treat pattern hair loss.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.